Cansino Biologics Inc(688185)

Cansino Biologics Inc(688185) Cansino Biologics Inc(688185) ( Cansino Biologics Inc(688185) ) announced on May 19 that the World Health Organization disclosed on its official website on May 19 that the company’s recombinant novel coronavirus vaccine (adenovirus type 5 vector) kweisa was included in the “emergency use list” (hereinafter referred to as “Eul”). After the product is incorporated into whoeul, the company still needs to conduct business negotiations with the intended countries on the future sales of the product. If the subsequent overseas countries increase the purchase and use of the product, it will have a certain positive impact on the performance of the listed company.